Once you’ve settled into a run routine, the next challenge can be staying motivated. Some days running feels energizing and exciting. Other days it feels hard to get out the door. In How to Start ...

Gold prices could taper off in the coming months before climbing in the long run, according to a strategist at UBS. Investors are likely seeing a late stage in bullion’s bull run, Joni Teves, precious ...

New to Nebraska, but not the Power Four, Paul Mubenga's looking to bring his SEC experience to the Huskers' starting offensive line rotation this fall. LINCOLN — Nebraska's offensive line is gearing ...

JUST A MEDAL. FOR ONE. RING THE BELL. THIS IS MY FAVORITE DAY OF THE YEAR. THIS WEEKEND, HUNDREDS OF GIRLS LACED UP THEIR SNEAKERS FOR A RACE AND A CELEBRATION. IT’S ALL PART OF GIRLS ON THE RUN. A ...

CNN correspondents and crew members were forced to run for cover in two separate incidents in Israel and Iran due to bombardments overhead. Anchor Erin Burnett and Jerusalem correspondent Jeremy ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

The Army will kick off its new retention bonus system next month, using physical fitness scores, technical expertise and commander evaluations to determine a soldier’s payout to reenlist. “We were ...

CHICAGO (WLS) -- Cook County it will continue funding the medical debt forgiveness program next year, once funds run out, Board of Commissioners President Tony Preckwinkle announced Tuesday. The ...

I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...

Hey there, fellow coder! 😊 Ever typed java -version in your Command Prompt only to be hit with a frustrating "java is not recognized as an internal or external command"? You're not alone—this common ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.